Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene
US6706268B1 · kind B1 · utility
0Cited by
7References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 13, 2000 |
| Grant date | Mar 16, 2004 |
| Priority date | — |
| Expiry date | Apr 22, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention is in the field of lymphadenopathy virus. This invention relates to a diagnostic means and method to detect the presence of DNA, RNA or antibodies of the lymphadenopathy retrovirus associated with the acquired immune deficiency syndrome or of the lymphadenopathy syndrome by the use of DNA fragments or the peptides encoded by said DNA fragments. The invention further relates to the DNA fragments, vectors comprising them and the proteins expressed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.